Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial investigating the pharmacokinetics of onapristone in healthy volunteers

X
Trial Profile

Phase I trial investigating the pharmacokinetics of onapristone in healthy volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 10 Sep 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Onapristone (Primary)
  • Indications Breast cancer; Endometrial cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 10 Sep 2015 Results published in the Cancer Chemotherapy and Pharmacology.
    • 21 Aug 2013 Status changed from not yet recruiting to recruiting, according to an Arno Therapeutics media release. The initiation follows Investigational Medicinal Product Dossier (IMPD) approval by French Health Authority ANSM in late July 2013.
    • 10 Apr 2013 This trial is expected to start in the second half of 2013, according to an Arno Therapeutics media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top